Pharma-Bio Serv (PBSV) Depreciation & Amortization (CF) (2010 - 2026)
Pharma-Bio Serv (PBSV) reported Depreciation & Amortization (CF) of $13640.0 for Q2 2026, down 27.7% year-over-year from $18866.0 in Q2 2025, and down 7.81% on a QoQ basis from $14796.0 in Q1 2026.
Pharma-Bio Serv (PBSV) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $13640.0 for Q2 2026.
- Depreciation & Amortization (CF) for Q2 2026 came in at $13640.0, down 27.7% year-over-year; the trailing twelve-month figure through Apr 2026 was $59997.0 (up 54.54% YoY), and the FY2025 annual result was $59866.0, up 156.81% from the prior year.
- Depreciation & Amortization (CF) came in at $13640.0 for Q2 2026 at Pharma-Bio Serv, down from $14796.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $18866.0 in Q2 2025 to a low of $4589.0 in Q3 2024.
- A 5-year average of $11711.4 and a median of $12881.0 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Across the five-year window, Depreciation & Amortization (CF) slumped 59.75% in 2024 and jumped 243.08% in 2025, its largest moves.
- Over 5 years, Depreciation & Amortization (CF) stood at $12800.0 in 2022, then plunged by 42.25% to $7392.0 in 2023, then dropped by 19.81% to $5928.0 in 2024, then jumped by 166.82% to $15817.0 in 2025, then declined by 13.76% to $13640.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $13640.0 (Q2 2026), $14796.0 (Q1 2026), and $15817.0 (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 11.59 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 39.09 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 38.21 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 1.17 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 9.96 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 4.13 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 41.45 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 146,000.00 |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 18.60 Mn |
| 10 | Pharma-Bio Serv | - | - | 902,041.00 | 13,640.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 13,640.00 |
| Apr 30, 2026 | 13,640.00 |
| Jan 31, 2026 | 14,796.00 |
| Jan 31, 2026 | 14,796.00 |
| Oct 31, 2025 | 15,817.00 |
| Oct 31, 2025 | 15,817.00 |
| Jul 31, 2025 | 15,744.00 |
| Jul 31, 2025 | 15,744.00 |
| Apr 30, 2025 | 18,866.00 |
| Apr 30, 2025 | 18,866.00 |
| Jan 31, 2025 | 9,439.00 |
| Jan 31, 2025 | 9,439.00 |
| Oct 31, 2024 | 5,928.00 |
| Oct 31, 2024 | 5,928.00 |
| Jul 31, 2024 | 4,589.00 |
| Jul 31, 2024 | 4,589.00 |
| Apr 30, 2024 | 5,508.00 |
| Apr 30, 2024 | 5,508.00 |
| Jan 31, 2024 | 7,286.00 |
| Jan 31, 2024 | 7,286.00 |